Annual eradication rate of bismuth‐containing quadruple therapy as second‐line treatment forHelicobacter pyloriinfection: A 15‐year prospective study at a tertiary hospital in Korea-Reference-Cited by-同舟云学术

Annual eradication rate of bismuth‐containing quadruple therapy as second‐line treatment forHelicobacter pyloriinfection: A 15‐year prospective study at a tertiary hospital in Korea

Published:2020-03-06 Issue:3 Volume:25 Page:
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:Helicobacter

Author:

Yoon Kichul¹²,Kim Nayoung¹^ORCID,Lee Jung Won³,Yoon Hyuk¹,Shin Cheol Min¹^ORCID,Park Young Soo¹,Lee Dong Ho¹

Affiliation:

1. Department of Internal Medicine Seoul National University Bundang Hospital Seongnam South Korea

2. Department of Internal Medicine and Digestive Disease Research Institute Wonkwang University Sanbon Hospital Gunpo South Korea

3. Department of Internal Medicine Samsung Changwon Hospital Sungkyunkwan University School of Medicine Changwon South Korea

Funder

National Research Foundation of Korea grant for the Global Core Research Center, funded by the Korean government

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hel.12685

Reference31 articles.

1. Helicobacter pyloriInfection

2. Diagnosis and Treatment of Peptic Ulcer Disease

3. Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis

4. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management

5. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on the second-line treatment ofHelicobacter pyloriinfection: a narrative review;Therapeutic Advances in Gastroenterology;2023-01

2. Quadruple Therapy;Helicobacter pylori;2023

3. Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea;Helicobacter;2022-12-07

4. Efficacy of Twice a Day Bismuth Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection;Journal of Personalized Medicine;2022-01-06

5. Second-Line Bismuth-Containing Quadruple Therapy for Helicobacterpylori Infection: A 12-Year Study of Annual Eradication Rates;Journal of Clinical Medicine;2021-07-24